Nexstim Plc key technology patent granted for Europe
Helsinki, Finland: 20 April 2016 - Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces that the European Patent Office (EPO) has now granted a key patent covering its method and system for displaying the electric field generated on the brain by transcranial magnetic stimulation (TMS).
Nexstim's Navigated Brain Stimulation (NBS) is the world's most advanced navigated TMS system and the only one able to model the electric field in the brain. E-field based navigation enables enhanced accuracy, repeatability and dose control, to transform TMS as a clinical tool for personalised therapy.
This approval is in addition to our patents granted in China, Japan and USA covering this validated E-field navigation. Nexstim's patent portfolio includes 80 granted patents and 76 pending patents in 26 patent families.
More info on Nexstim's website.
Next > Confo Therapeutics appoints Dr Christel Menet as Chief Scientific Officer
Previous > Avantium raises € 20 million in a financing round led by PMV